欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
EL/H/0345/003
药品名称
Co-Fineria
活性成分
metformin hydrochloride 1000.0 mg
SITAGLIPTIN 100.0 mg
剂型
Modified-release tablet
上市许可持有人
Medical Pharmaquality S.A. 54 Elaion Street 145 64 Athens, Greece
参考成员国 - 产品名称
Greece (GR)
互认成员国 - 产品名称
许可日期
2022/03/01
最近更新日期
2024/04/26
药物ATC编码
A10BD07 metformin and sitagliptin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PAR Summary
|
PL_H_0725_001_003_DC Summary nongenrics
Date of last change:2022/10/18
PAR
|
PL_H_0725_001_003_DC PAR
Date of last change:2022/10/18
Final SPC
|
131sitamet_smpc_clean_0723_0724_0725_0726_24_02_2022
Date of last change:2022/06/02
Final PL
|
131sitamet_pil_clean_0723_0724_0725_0726_24_02_2022
Date of last change:2022/06/02
Final Labelling
|
131_sitamet_lab_clean_0723_0724_0725_0726_16_02_2022
Date of last change:2022/06/02
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase